Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Phase I GI Oncology, Drug Development

Wells Messersmith

MD

🏢University of Colorado Cancer Center🌐USA

Associate Director, Clinical Research

42
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Wells Messersmith at Colorado has contributed to phase I and early clinical development in GI oncology, including early trials of cetuximab in colorectal cancer and development of novel agents for CRC and other GI malignancies. His work on phase I GI oncology clinical pharmacology and his contributions to CRC drug development represent extensive participation in defining treatments now standard in GI cancer.

Share:

🧪Research Fields 研究领域

colorectal cancer phase I
GI oncology early phase
cetuximab development
VEGFR2 early phase trials
GI cancer clinical pharmacology

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-03-01 | All information from publicly available academic sources

关注 Wells Messersmith 的研究动态

Follow Wells Messersmith's research updates

留下邮箱,当我们发布与 Wells Messersmith(University of Colorado Cancer Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment